Search results for

Ben Moshinsky, London

Singapore's government could soon consolidate the way that it regulates medicines and other health-related products. At the moment, the Health Sciences Authority (HSA), Singapore's equivalent of the US Food And Drug Administration (FDA), regulates medicines and other health-related products. The HSA's powers are contained in a wide variety of legislation, such as the Medicines Act, the Poisons Act, the Sale of Drugs Act and the Medicines (Advertisement and Sale) Act. Through these laws, the HSA controls the manufacture, import, distribution, promotion and sale of health-related products in Singapore.

On June 21 2005, the Secretary of Health issued Administrative Order Number 2005-0016, entitled General Policies and Guidelines Governing Brand Names of Products for Registration with the Bureau of Food and Drugs (BFAD). BFAD officials are thought to believe that IP issues relating to brand names have impeded their ability to implement effectively the misbranding provisions of Republic Act 3720, known as the Food, Drugs and Devices and Cosmetics Act. The most important features of the new Order are:

Sam Mamudi, New York

Emma Barraclough, Hong Kong and Sam Mamudi, New York

Emma Barraclough, Hong Kong

Indian politicians are discussing whether to make another amendment to the country's patent rules. On June 20 2005, the government notified the Patents (Second Amendment) Rules, 2005. It was widely expected that the draft Rules would reverse the exorbitant hike in the filing fee introduced in a previous amendment to the Rules.

In the recent case of Industria De Diseno Textil SA v Edition Concept Sdn Bhd [2005 3 MLJ 347], the defendant filed a notice of motion to set aside and expunge the plaintiff's trade mark "Zara" on the grounds that it had used the Zara mark and made it well-known in Malaysia in respect of clothing well before the plaintiff's trade mark was approved.

Through regular inspections of trade, Argentine Customs often realized that counterfeit goods were circulating, but their hands were tied. Customs authorities were not empowered to detain goods infringing IP rights.

In June 2003, the US Supreme Court issued a ruling limiting the claims of ownership over a creative work. Joseph M Beck examines how that decision has shaped IP case law over the past two years